We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biopharma Credit Plc | LSE:BPCR | London | Ordinary Share | GB00BDGKMY29 | ORD USD0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.852 | 0.852 | 0.854 | 0.858 | 0.85 | 0.858 | 1,203,822 | 16:28:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Finance Services | 135.74M | 108.45M | 0.0914 | 7.55 | 1.01B |
BioPharma Credit plc
(the "Company")
TRANSACTION IN OWN SHARES
BioPharma Credit PLC announces that today it has purchased the following number of its ordinary shares of US$0.01 each through J.P. Morgan Securities plc into treasury.
Ordinary Shares: BPCR LN
Date of purchase: 20 January 2025
Number of ordinary shares purchased: 250,000
Lowest price per share: $0.8540
Highest price per share: $0.8540
Trading venue: JPM SI
Ordinary Shares: BPCR LN
Date of purchase: 20 January 2025
Number of ordinary shares purchased: 250,000
Lowest price per share: $0.8540
Highest price per share: $0.8540
Trading venue: JPM OTC
Ordinary Shares: BPCR LN
Date of purchase: 20 January 2025
Number of ordinary shares purchased: 150,000
Lowest price per share: $0.8520
Highest price per share: $0.8540
Trading venue: LSE
Aggregate volume per date per trading venue: 650,000
Weighted average price per day per trading venue: $0.8539
Following the above transaction, the Company holds 192,164,795 of its ordinary shares in treasury and has 1,181,767,272 ordinary shares in issue (excluding treasury shares). Therefore, the total number of voting rights in the Company is 1,181,767,272. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
+44 (0) 333 300 1932
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only specialist debt investor to the life sciences industry and joined the LSE in March 2017. BioPharma Credit PLC seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. BioPharma Credit PLC seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
1 Year Biopharma Credit Chart |
1 Month Biopharma Credit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
